Jonassen T E, Christensen S, Kwon T H, Langhoff S, Salling N, Nielsen S
Department of Pharmacology, the Panum Institute, University of Copenhagen, 2200 Copenhagen N, Denmark.
Am J Physiol Renal Physiol. 2000 Dec;279(6):F1101-9. doi: 10.1152/ajprenal.2000.279.6.F1101.
The present study was performed to investigate the renal handling of water in rats with decompensated liver cirrhosis. Liver cirrhosis was induced by intraperitoneal administration of carbon tetrachloride twice weekly for 16 wk. Control rats were treated with vehicle. The cirrhotic rats developed severe disturbances in water homeostasis: urine production was decreased and hyperosmotic, the rats had significantly decreased plasma sodium concentration and ascites, and the ability to excrete an intravenous water load was significantly impaired. Plasma concentrations of vasopressin and aldosterone were increased. Mean arterial pressure, glomerular filtration rate (GFR), and fractional lithium excretion were decreased. Acute vasopressin type 2-receptor blockade with the selective nonpeptide antagonist OPC-31260 (800 microg. kg(-1). h(-1)) was performed during conditions whereby volume depletion was prevented by computer-driven, servo-controlled intravenous volume replacement with 150 mM glucose. The aquaretic response to OPC-31260 was similar in cirrhotic and control rats. However, the OPC 31260-induced rises in fractional water excretion (delta V/GFR; +24%) and fractional distal water excretion (delta V/C(Li); +46%) were significantly increased in the cirrhotic rats, where V is flow rate and delta is change. This suggests that vasopressin-mediated renal water reabsorption capacity was increased in the cirrhotic rats. Semiquantitative immunoblotting revealed that the expression of the vasopressin-regulated water channel aquaporin-2 was unchanged in membrane fractions of both whole kidney and inner medulla from cirrhotic rats. Together, these results suggest a relative escape from vasopressin on collecting duct water reabsorption in rats with decompensated liver cirrhosis.
本研究旨在探讨失代偿期肝硬化大鼠的肾脏对水的处理情况。通过每周两次腹腔注射四氯化碳,持续16周诱导大鼠肝硬化。对照组大鼠注射赋形剂。肝硬化大鼠出现严重的水平衡紊乱:尿量减少且呈高渗性,血浆钠浓度显著降低,出现腹水,静脉注射水负荷后的排泄能力显著受损。血管加压素和醛固酮的血浆浓度升高。平均动脉压、肾小球滤过率(GFR)和锂排泄分数降低。在通过计算机驱动的伺服控制静脉输注150 mM葡萄糖防止容量耗竭的条件下,用选择性非肽拮抗剂OPC - 31260(800 μg·kg⁻¹·h⁻¹)进行急性血管加压素2型受体阻断。肝硬化大鼠和对照大鼠对OPC - 31260的利水反应相似。然而,在肝硬化大鼠中,OPC 31260诱导的水排泄分数(ΔV/GFR;+24%)和远端水排泄分数(ΔV/C(Li);+46%)的升高显著增加,其中V为流速,Δ为变化量。这表明肝硬化大鼠中血管加压素介导的肾脏水重吸收能力增强。半定量免疫印迹显示,肝硬化大鼠全肾和髓质内的膜部分中,血管加压素调节的水通道水通道蛋白 - 2的表达未发生变化。总之,这些结果表明失代偿期肝硬化大鼠的集合管水重吸收存在相对的血管加压素抵抗。